Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 133

1.

Estimating extra length of stay due to healthcare-associated infections before and after implementation of a hospital-wide infection control program.

Arefian H, Hagel S, Fischer D, Scherag A, Brunkhorst FM, Maschmann J, Hartmann M.

PLoS One. 2019 May 17;14(5):e0217159. doi: 10.1371/journal.pone.0217159. eCollection 2019.

2.

Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community acquired pneumonia - results from the prospective observational PROGRESS study.

Ahnert P, Creutz P, Horn K, Schwarzenberger F, Kiehntopf M, Hossain H, Bauer M, Brunkhorst FM, Reinhart K, Völker U, Chakraborty T, Witzenrath M, Löffler M, Suttorp N, Scholz M; PROGRESS Study Group.

Crit Care. 2019 Apr 4;23(1):110. doi: 10.1186/s13054-019-2316-x.

3.

Nudge to better care - blood cultures and catheter-related bloodstream infections in Germany at two points in time (2006, 2015).

Salm F, Schwab F, Behnke M, Brunkhorst FM, Scherag A, Geffers C, Gastmeier P.

Antimicrob Resist Infect Control. 2018 Nov 21;7:141. doi: 10.1186/s13756-018-0432-z. eCollection 2018.

4.

Effectiveness of a hospital-wide infection control programme on the incidence of healthcare-associated infections and associated severe sepsis and septic shock: a prospective interventional study.

Hagel S, Ludewig K, Pletz MW, Frosinski J, Moeser A, Wolkewitz M, Gastmeier P, Harbarth S, Brunkhorst FM, Kesselmeier M, Scherag A.

Clin Microbiol Infect. 2019 Apr;25(4):462-468. doi: 10.1016/j.cmi.2018.07.010. Epub 2018 Jul 21.

5.

Hemophagocytic Lymphohistiocytosis: Potentially Underdiagnosed in Intensive Care Units.

Lachmann G, Spies C, Schenk T, Brunkhorst FM, Balzer F, La Rosée P.

Shock. 2018 Aug;50(2):149-155. doi: 10.1097/SHK.0000000000001048.

PMID:
30010630
6.

[Current aspects of the definition and diagnosis of sepsis and antibiotic resistance].

Brunkhorst FM, Gastmeier P, Abu Sin M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 May;61(5):562-571. doi: 10.1007/s00103-018-2730-2. Review. German.

PMID:
29644442
7.

The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.

Elke G, Bloos F, Wilson DC, Brunkhorst FM, Briegel J, Reinhart K, Loeffler M, Kluge S, Nierhaus A, Jaschinski U, Moerer O, Weyland A, Meybohm P; SepNet Critical Care Trials Group.

Crit Care. 2018 Mar 21;22(1):79. doi: 10.1186/s13054-018-2001-5.

8.

[Sepsis-3 : What has been confirmed in therapy?]

David S, Brunkhorst FM.

Internist (Berl). 2017 Dec;58(12):1264-1271. doi: 10.1007/s00108-017-0338-5. Review. German.

PMID:
29046941
9.

International registry on the use of the CytoSorb® adsorber in ICU patients : Study protocol and preliminary results.

Friesecke S, Träger K, Schittek GA, Molnar Z, Bach F, Kogelmann K, Bogdanski R, Weyland A, Nierhaus A, Nestler F, Olboeter D, Tomescu D, Jacob D, Haake H, Grigoryev E, Nitsch M, Baumann A, Quintel M, Schott M, Kielstein JT, Meier-Hellmann A, Born F, Schumacher U, Singer M, Kellum J, Brunkhorst FM.

Med Klin Intensivmed Notfmed. 2017 Sep 4. doi: 10.1007/s00063-017-0342-5. [Epub ahead of print] Review.

PMID:
28871441
10.

[Epistemology in the intensive care unit-what is the purpose of a definition? : Paradigm shift in sepsis research].

Dickmann P, Scherag A, Coldewey SM, Sponholz C, Brunkhorst FM, Bauer M.

Anaesthesist. 2017 Aug;66(8):622-625. doi: 10.1007/s00101-017-0315-3. German.

PMID:
28500500
11.

Chronic Critical Illness from Sepsis Is Associated with an Enhanced TCR Response.

Borken F, Markwart R, Requardt RP, Schubert K, Spacek M, Verner M, Rückriem S, Scherag A, Oehmichen F, Brunkhorst FM, Rubio I.

J Immunol. 2017 Jun 15;198(12):4781-4791. doi: 10.4049/jimmunol.1700142. Epub 2017 May 8.

12.

Study on the utility of a statewide counselling programme for improving mortality outcomes of patients with Staphylococcus aureus bacteraemia in Thuringia (SUPPORT): a study protocol of a cluster-randomised crossover trial.

Weis S, Hagel S, Schmitz RP, Scherag A, Brunkhorst FM, Forstner C, Löffler B, Pletz MW.

BMJ Open. 2017 Apr 8;7(4):e013976. doi: 10.1136/bmjopen-2016-013976.

13.

Effect of pre-operative octenidine nasal ointment and showering on surgical site infections in patients undergoing cardiac surgery.

Reiser M, Scherag A, Forstner C, Brunkhorst FM, Harbarth S, Doenst T, Pletz MW, Hagel S.

J Hosp Infect. 2017 Feb;95(2):137-143. doi: 10.1016/j.jhin.2016.11.004. Epub 2016 Nov 18.

PMID:
28109620
14.

Hospital-related cost of sepsis: A systematic review.

Arefian H, Heublein S, Scherag A, Brunkhorst FM, Younis MZ, Moerer O, Fischer D, Hartmann M.

J Infect. 2017 Feb;74(2):107-117. doi: 10.1016/j.jinf.2016.11.006. Epub 2016 Nov 21. Review.

PMID:
27884733
15.

Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.

Keh D, Trips E, Marx G, Wirtz SP, Abduljawwad E, Bercker S, Bogatsch H, Briegel J, Engel C, Gerlach H, Goldmann A, Kuhn SO, Hüter L, Meier-Hellmann A, Nierhaus A, Kluge S, Lehmke J, Loeffler M, Oppert M, Resener K, Schädler D, Schuerholz T, Simon P, Weiler N, Weyland A, Reinhart K, Brunkhorst FM; SepNet–Critical Care Trials Group.

JAMA. 2016 Nov 1;316(17):1775-1785. doi: 10.1001/jama.2016.14799.

PMID:
27695824
16.

Genetic Factors of the Disease Course after Sepsis: A Genome-Wide Study for 28Day Mortality.

Scherag A, Schöneweck F, Kesselmeier M, Taudien S, Platzer M, Felder M, Sponholz C, Rautanen A, Hill AVS, Hinds CJ, Hossain H, Suttorp N, Kurzai O, Slevogt H, Giamarellos-Bourboulis EJ, Armaganidis A, Trips E, Scholz M, Brunkhorst FM.

EBioMedicine. 2016 Oct;12:239-246. doi: 10.1016/j.ebiom.2016.08.043. Epub 2016 Sep 15.

17.

[Hemophagocytic lymphohistiocytosis : A diagnostic challenge on the ICU].

Lachmann G, La Rosée P, Schenk T, Brunkhorst FM, Spies C.

Anaesthesist. 2016 Oct;65(10):776-786. Review. German.

PMID:
27612865
18.

Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.

Bloos F, Trips E, Nierhaus A, Briegel J, Heyland DK, Jaschinski U, Moerer O, Weyland A, Marx G, Gründling M, Kluge S, Kaufmann I, Ott K, Quintel M, Jelschen F, Meybohm P, Rademacher S, Meier-Hellmann A, Utzolino S, Kaisers UX, Putensen C, Elke G, Ragaller M, Gerlach H, Ludewig K, Kiehntopf M, Bogatsch H, Engel C, Brunkhorst FM, Loeffler M, Reinhart K; for SepNet Critical Care Trials Group.

JAMA Intern Med. 2016 Sep 1;176(9):1266-76. doi: 10.1001/jamainternmed.2016.2514.

PMID:
27428731
19.

C-Terminal Alpha-1 Antitrypsin Peptide: A New Sepsis Biomarker with Immunomodulatory Function.

Blaurock N, Schmerler D, Hünniger K, Kurzai O, Ludewig K, Baier M, Brunkhorst FM, Imhof D, Kiehntopf M.

Mediators Inflamm. 2016;2016:6129437. doi: 10.1155/2016/6129437. Epub 2016 Jun 13.

20.

[Treatment of penicillin-sensitive staphylococcus aureus - in reply].

Weis S, Kaasch AJ, Rieg S, Löffler B, Hagel S, Forstner C, Brunkhorst FM, Pletz MW.

Dtsch Med Wochenschr. 2016 May;141(10):675. doi: 10.1055/s-0041-108937. Epub 2016 May 13. German. No abstract available.

PMID:
27176056

Supplemental Content

Loading ...
Support Center